Letter by Zaghloul et al Regarding Article, “Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX”
- 1 July 2022
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 15 (7) , 635
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIXCirculation: Cardiovascular Interventions, 2022
- The efficacy and safety of cangrelor in single vessel vs multivessel percutaneous coronary intervention: Insights from CHAMPION PHOENIXClinical Cardiology, 2019
- Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled TrialsDiabetes Therapy, 2019
- Intravenous Platelet Blockade with Cangrelor during PCINew England Journal of Medicine, 2009